Area of research
Genetics · Cancer Research
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Management of metastatic bone disease, and Brain Metastases and Treatment.
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses
Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium
NXPE1 alters the sialoglycome by acetylating sialic acids in the human colon
Risk Factors, Indications, and Effectiveness of Cerebrospinal Fluid Diversion in Patients With High-Grade Glioma–Associated Hydrocephalus: A Systematic Review and Meta-Analysis
Effects of diagnosed depression on postoperative outcomes after microvascular decompression for patients with trigeminal neuralgia
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers
Cancer therapy with antibodies
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review
Leptomeningeal metastatic disease: new frontiers and future directions
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies
Machine learning to detect the SINEs of cancer
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid
The rapid and highly parallel identification of antibodies with defined biological activities by SLISY
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations
Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3-year results with the application of a flow diverter specific occlusion classification
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer